Another successful FDA inspection at Alpex Pharma SA

On May 2017 Alpex Pharma has successfully passed a GMP inspection by US FDA and the outcome once more was satisfactory....

Read more

R&D Projects

R&D Projects

Alpex Pharma has undertaken extensive development activities for third parties.
It also identifies product opportunities and develops them internally in view of finding interested licensing partners.
Our development plan include drug-excipient compatibility studies, analytical method development, definition of formula, cleaning development, non-pivotal stability studies and reporting.

Projects currently under developement

Alpex ID Code # A190
Drug category: Minerals & Vitamins Prescription: OTC
Dosage form: Sachet License granted: EU
Indication: Osteoporosis Free available territories: Free Territories
Page: < ... 2 3